Parameters group studied (n = 10)

Renal tissue homogenate

TNF-α (ng/ml)

MDA (nmol/g)

XO (U/g)

NO (µmol/g)

MPO (U/g)

Normal control gp.

5.35bcde ± 0.43

1.2bcde ± 0.15

1.29bcd ± 0.05

0.6bcd ± 0.03

2.1bcd ± 0.05

Diabetic gp.

17.78acde ± 0.99

3.7acde ± 0.41

1.97acde ± 0.08

0.8acde ± 0.02

3.7acde ± 0.51

Ischemic reperfused (IR) gp.

19.47abde ± 0.82

4.8abde ± 0.5

2.1abde ± 0.05

0.9abde ±0.025

6.6abde ± 0.27

Diabetic + I/R gp.

29.15abce ± 0.65

6.6abce ± 0.27

2.3abce ± 0.03

1.3abce ± 0.09

8.7abce ± 0.41

Sitaglipten treated (Diabetic + I/R) gp.

6.52abcd ± 0.72

1.7abcd ± 0.3

1.3bcd ± 0.09

0.6bcd ± 0.04

2.3bcd ± 0.41

F (p)

1758.387* (<0.001)

410.522* (<0.001)

538.407* (<0.001)

356.989* (<0.001)

616.495* (<0.001)

LSD (5%)

0.667

0.311

0.057

0.040

0.327